Literature DB >> 19538576

Expert review of the evidence base for self-therapy of travelers' diarrhea.

Herbert L DuPont1, Charles D Ericsson, Michael J G Farthing, Sherwood Gorbach, Larry K Pickering, Lars Rombo, Robert Steffen, Thomas Weinke.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19538576     DOI: 10.1111/j.1708-8305.2009.00300.x

Source DB:  PubMed          Journal:  J Travel Med        ISSN: 1195-1982            Impact factor:   8.490


× No keyword cloud information.
  19 in total

1.  A Comparison of Pretravel Health Care, Travel-Related Exposures, and Illnesses among Pediatric and Adult U.S. Military Beneficiaries.

Authors:  David P Ashley; Jamie Fraser; Heather Yun; Anjali Kunz; Mary Fairchok; David Tribble; Indrani Mitra; Mark D Johnson; Patrick W Hickey; Anuradha Ganesan; Robert G Deiss; Tahaniyat Lalani
Journal:  Am J Trop Med Hyg       Date:  2019-05       Impact factor: 2.345

2.  Inflammatory bowel disease in travelers: choosing the right vaccines and check-ups.

Authors:  Maria Esteve; Carme Loras; Ester García-Planella
Journal:  World J Gastroenterol       Date:  2011-06-14       Impact factor: 5.742

Review 3.  Paediatric travel medicine: vaccines and medications.

Authors:  Mike Starr
Journal:  Br J Clin Pharmacol       Date:  2013-06       Impact factor: 4.335

4.  In vitro antimicrobial susceptibility of bacterial enteropathogens isolated from international travelers to Mexico, Guatemala, and India from 2006 to 2008.

Authors:  Jeannette Ouyang-Latimer; Syed Jafri; Audrey VanTassel; Zhi-Dong Jiang; Kaur Gurleen; Savio Rodriguez; Ranjan K Nandy; Thandavaryan Ramamurthy; Santanu Chatterjee; Robin McKenzie; Robert Steffen; Herbert L DuPont
Journal:  Antimicrob Agents Chemother       Date:  2010-11-29       Impact factor: 5.191

Review 5.  Advances in the treatment of travelers' diarrhea.

Authors:  Mercedes Paredes-Paredes; Jose Flores-Figueroa; Herbert L Dupont
Journal:  Curr Gastroenterol Rep       Date:  2011-10

Review 6.  Recent advances in understanding enteric pathogenic Escherichia coli.

Authors:  Matthew A Croxen; Robyn J Law; Roland Scholz; Kristie M Keeney; Marta Wlodarska; B Brett Finlay
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

Review 7.  Rifaximin: a unique gastrointestinal-selective antibiotic for enteric diseases.

Authors:  Hoonmo L Koo; Herbert L DuPont
Journal:  Curr Opin Gastroenterol       Date:  2010-01       Impact factor: 3.287

8.  ACG Clinical Guideline: Diagnosis, Treatment, and Prevention of Acute Diarrheal Infections in Adults.

Authors:  Mark S Riddle; Herbert L DuPont; Bradley A Connor
Journal:  Am J Gastroenterol       Date:  2016-04-12       Impact factor: 10.864

Review 9.  Use of rifaximin in gastrointestinal and liver diseases.

Authors:  Rani H Shayto; Rachel Abou Mrad; Ala I Sharara
Journal:  World J Gastroenterol       Date:  2016-08-07       Impact factor: 5.742

10.  Management of Acute Diarrheal Illness During Deployment: A Deployment Health Guideline and Expert Panel Report.

Authors:  Mark S Riddle; Gregory J Martin; Clinton K Murray; Timothy H Burgess; Patrick Connor; James D Mancuso; Elizabeth R Schnaubelt; Timothy P Ballard; Jamie Fraser; David R Tribble
Journal:  Mil Med       Date:  2017-09       Impact factor: 1.437

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.